IDOR 11342831
Alternative Names: IDO-090; IDOR-1134-2831Latest Information Update: 01 Aug 2024
At a glance
- Originator Idorsia Pharmaceuticals
- Class Bacterial vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Clostridium difficile infections